1. Home
  2. KROS vs ZKH Comparison

KROS vs ZKH Comparison

Compare KROS & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • ZKH
  • Stock Information
  • Founded
  • KROS 2015
  • ZKH 1998
  • Country
  • KROS United States
  • ZKH China
  • Employees
  • KROS N/A
  • ZKH N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • KROS Health Care
  • ZKH
  • Exchange
  • KROS Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • KROS 460.6M
  • ZKH 578.4M
  • IPO Year
  • KROS 2020
  • ZKH 2023
  • Fundamental
  • Price
  • KROS $11.00
  • ZKH $3.56
  • Analyst Decision
  • KROS Buy
  • ZKH Buy
  • Analyst Count
  • KROS 11
  • ZKH 1
  • Target Price
  • KROS $45.33
  • ZKH $4.00
  • AVG Volume (30 Days)
  • KROS 2.1M
  • ZKH 33.1K
  • Earning Date
  • KROS 02-26-2025
  • ZKH 03-18-2025
  • Dividend Yield
  • KROS N/A
  • ZKH N/A
  • EPS Growth
  • KROS N/A
  • ZKH N/A
  • EPS
  • KROS N/A
  • ZKH N/A
  • Revenue
  • KROS $651,000.00
  • ZKH $1,259,541,805.00
  • Revenue This Year
  • KROS $303.27
  • ZKH $0.49
  • Revenue Next Year
  • KROS N/A
  • ZKH $12.88
  • P/E Ratio
  • KROS N/A
  • ZKH N/A
  • Revenue Growth
  • KROS 8037.50
  • ZKH 3.49
  • 52 Week Low
  • KROS $9.78
  • ZKH $2.62
  • 52 Week High
  • KROS $73.00
  • ZKH $21.91
  • Technical
  • Relative Strength Index (RSI)
  • KROS 24.79
  • ZKH 50.21
  • Support Level
  • KROS $11.04
  • ZKH $3.50
  • Resistance Level
  • KROS $11.99
  • ZKH $3.70
  • Average True Range (ATR)
  • KROS 0.60
  • ZKH 0.20
  • MACD
  • KROS 1.20
  • ZKH -0.00
  • Stochastic Oscillator
  • KROS 43.99
  • ZKH 16.05

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: